Director, US TUKYSA Brand Strategy Lead

Location: New York

## Director, US TUKYSA Brand Strategy Lead Bewerben:
United States
- New York
- New York City:
United States
- Connecticut
- Groton:
United States
- Pennsylvania
- Collegeville:
Vollzeit:
Heute ausgeschrieben:
4964667
** What You Will Achieve
** Pfizer Commercial Oncology is introducing the world to the next era of cancer care. With a growing portfolio of novel therapies, industry-leading R&D, and a goal of delivering eight breakthroughs by 2030 across major cancer types, we're translating cutting-edge science into market-shaping impact. Here, you'll partner with exceptional colleagues across scientific, medical, and manufacturing teams, backed by advanced digital and AI-enabled infrastructure and the authority to accelerate medicines from discovery to delivery.

Guided by our values of courage, excellence, equity, and joy, you'll have the opportunity to stretch your skills and build a career that evolves with you — across teams, roles, and the Pfizer enterprise.
** Join us to make history — for patients, for their families, for the future.
** At Pfizer Oncology, our mission is to  Outdo Cancer  by developing transformative therapies that make a meaningful impact for patients. Pfizer Oncology currently boasts an industry-leading portfolio spanning breast as well as genitourinary (GU) cancers, hematology-oncology, gastrointestinal-oncology, and thoracic cancers. The US Breast Cancer Business is one of the largest businesses within Pfizer Oncology. It is anchored by a multibillion-dollar asset IBRANCE, as well as TUKYSA in metastatic breast cancer, and a robust pipeline of breast cancer innovation.  

TUKYSA is entering one of the most consequential windows in the brand's history with the anticipated launch of the HER2

CLIMB-05 first-line maintenance (1

Lm) indication in human epidermal growth factor receptor 2-positive (HER2+) metastatic breast cancer (mBC, PDUFA Oct 17, 2026). HER2

CLIMB-05 marks a new era for the Pfizer Breast Cancer Franchise, with TUKYSA poised as the franchise growth driver. TUKYSA is also indicated for HER2+ metastatic colorectal cancer (mCRC). Over the next years, several pivotal trial readouts are anticipated across both mBC and mCRC for TUKYSA.  The Strategy & Performance Lead is a critical strategic and operational role. Operating as an individual contributor in a highly matrixed environment, the role drives US commercial strategic planning, business operations, and demand-based performance management.

The ideal candidate is a strategic thinker who turns complex, ambiguous data into clear commercial direction — pairing analytical rigor and data-driven decision-making with the communication skills and influence to move senior cross-functional stakeholders toward it. US launch exposure is strongly valued. The Director, US TUKYSA Strategy & Performance Lead will report to the Sr. Director, US TUKYSA Commercial & Marketing Team Lead and be part of a mission-driven, innovative, and talented team of diverse colleagues.

** ROLE RESPONSIBILITIES
** Key responsibilities include but are not limited to:
** Strategic Planning*
* * Own the strategic agenda for TUKYSA: proactively surfacing issues that need a decision early, framing the options and implications, and drive recommendations to resolution with the relevant business and functional leaders
* Define the 3-year US commercial strategy across both metastatic breast cancer and metastatic colorectal cancer
* Develop the competitive strategy and positioning for TUKYSA in the evolving HER2+ mBC treatment landscape
* Build and advocate the case for select and targeted TUKYSA's prioritization within enterprise customer-facing resources, partnering with Account Marketing and Account Management leadership
* Lead strategic assessment of mCRC…